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Introduction: This study explored implant user and healthcare provider experiences of
accessing and providing contraceptive implant removal services in Gaborone, Botswana,
following introduction of the implant in the public sector in 2016.We sought to understand
reasons for satisfaction and dissatisfaction with services and their potential impact on
wider perceptions of the implant, including influence on future uptake.
Methods: Qualitative data were collected through in-depth interviews. Participants
comprised ten women who had previously undergone implant removal, and ten providers
whose work included provision of implant insertion and removal. Data were analyzed
using thematic content analysis.
Results: Seven of the ten users in this study had experienced a delay between
initial request and undergoing implant removal. This interval ranged from <1 week to
3 months. Users identified the principal barriers to accessing implant removal services
as lack of access to trained removal providers, inconvenient appointment times, and
provider resistance to performing removal. Nine of the ten providers in this study
had experienced barriers to providing implant removal, including insufficient training,
lack of equipment, lack of time, and lack of a referral pathway for difficult removals.
Despite experiencing barriers in accessing removal, users’ perceptions of the implant
remained generally positive. Providers were concerned that ongoing negative user
experiences of removal services would damage wider perceptions of the implant.
Howett et al. Implant Removal Services in Botswana
Conclusion: Introduction of the contraceptive implant in Botswana has been an
important strategy in increasing contraceptive choice. Following an initial focus on
provision of insertion services, the development of comparable, accessible removal
services is critical to ensuring that the implant remains a desirable contraceptive option
and is vital to upholding women’s reproductive health rights. The experiences of users
and providers in this study can inform the ongoing development of services for implant
insertion and removal in Botswana and other lower-resource settings.
Keywords: contraceptive implant, implant removal, long-acting reversible contraception, botswana, qualitative
study
INTRODUCTION
The subdermal contraceptive implant is a convenient and highly
effective (1, 2) long-acting reversible method of contraception
(LARC) which is medically safe for most women (3). Over
the past decade, there has been a global increase in implant
use (4) and uptake has been particularly marked in sub-
Saharan Africa (5). The Botswana Ministry of Health and
Wellness (MoHW) established a public sector implant program
in 2016 (6), providing both a one-rod etonogestrel implant
(ImplanonNXT R©, Merck), and a two-rod levonorgestrel implant
(Jadelle R©, Bayer).
Increasing implant demand has created a corresponding
demand for implant services, both for initiation and for
discontinuation, as the method is dependent on access to trained
healthcare providers for insertion and removal. The implant has
a lifespan of 3–5 years of contraceptive effectiveness, depending
onmodel, after which it should be replaced. Users may also opt to
discontinue before its full lifespan has elapsed due to problematic
side effects (most commonly heavy or irregular vaginal bleeding)
and desire to conceive (7–10).
In order to uphold women’s reproductive rights, they should
be empowered to exercise full contraceptive autonomy (11),
which includes the right to discontinue any given contraceptive
method at their choosing (12). Thus, access to removal
services is essential from the moment of implant introduction.
Unfortunately, in many settings upscaling of removal services
has not always kept pace with that of insertion services (4).
Perception and subsequent uptake of the implant have previously
been damaged by perceived difficulty in accessing removal
services, including with Norplant R© (Wyeth-Ayerst), a six-rod
levonorgestrel predecessor to the current implant models, in the
1990s (13) and more recently with Implanon NXT R© in South
Africa (14).
We understand the reasons why women request implant
removal, but there is a lack of information on women’s
experiences with accessing removal services. This information is
particularly sparse in resource-limited settings where healthcare
systems face multiple concurrent challenges. We aimed to gain
Abbreviations: DMPA, depomedroxyprogesterone acetate; HIV, human
immunodeficiency virus; IUD, intrauterine device; MoHW,Ministry of Health and
Wellness; NGO, non-governmental organization; REDCap, Research Electronic
Data Capture; SRH, sexual and reproductive health.
an understanding of experiences in accessing and providing
contraceptive implant removal services. We explored this issue
from both sides: implant users who have sought removal,
and healthcare providers who have experience in removing
implants. We sought to identify reasons for satisfaction and
dissatisfaction with the process, and to determine whether
challenges encountered in accessing implant removals have
had an impact upon wider perceptions of this method
of contraception, including any influence on future uptake.
This research has relevance for the provision of implant
insertion and removal services in Botswana, as well as




This study was conducted in Gaborone, Botswana’s capital city
and largest urban center, between April 2018 and July 2018.
About 11% of Botswana’s total population resides in Gaborone,
and 64% of Botswana’s total population resides in urban areas
(15). Women who had previously used and then discontinued
the implant (“users”) were interviewed at a non-governmental
organization (NGO) sexual and reproductive health (SRH) clinic
but had received implant services in both government and NGO
clinics. The NGO clinic provides SRH services to residents of
Gaborone and its surrounding settlements, and also acts as
a referral center for other local clinics. Healthcare providers
(“providers”) were interviewed at their place of work.
Study Design
Qualitative data were collected through in-depth individual
interviews using interview guides which were developed for this
study. These guides were pre-piloted with women and providers
who were not participants. The interview guide consisted of
a brief introduction to the purpose of the study, followed
by questions on socio-demographics, reproductive/contraceptive
history (for users) or professional background (for providers).
Users were asked about their decision-making surrounding
initiation and discontinuation of the implant. Both groups were
asked about their experiences with implant removal services, and
their overall experiences and perceptions of the implant as a
method of contraception. Ethical approval was obtained from
the Botswana Health Research and Development Committee,
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the University of Botswana Research Ethics Committee, and
University College London (UK) Research Ethics Committee.
Study Participants and Recruitment
Eligible users were women aged 18 years or older who had
undergone implant removal in the Botswana public sector health
services or an NGO clinic within the past 3 months (we
unintentionally interviewed one participant who had undergone
implant removal within the past 6 months but still included
this user in the analysis). We did not specify early removal of
the implant (i.e., before its full lifespan had elapsed) amongst
the inclusion criteria; however, all users in our study had
discontinued early. Users were identified opportunistically when
they presented to the NGO clinic for any reason.
Eligible providers had undergone implant training within the
Botswana implant program, and currently work in provision of
contraceptive services including implant insertion and removal.
Providers were identified from the Botswana MoHW list of
implant providers. A sample size of approximately ten users and
five providers was defined in the study protocol, but we recruited
until the point of data saturation.
All potential participants who were approached consented to
be interviewed.
Data Collection
Interviews were arranged at a time and place convenient for
each participant. Written informed consent was obtained prior
to participation. Interviews were conducted in the participant’s
preferred language (Setswana or English), in a private room,
and with only the interviewer and the participant present. All
interviews were digitally audio-recorded and anonymized. User
interviews were conducted by author OB (a female research
assistant). Provider interviews were conducted by authors AMG
(a female research fellow) and CB (a female doctoral student). All
three interviewers are experienced in conducting SRH research
and hold relevant master’s level qualifications, AMG also holds
a medical degree and is experienced in providing clinical care in
this research setting. Users were compensated 50 Botswana Pula
(≈ 4 USD); providers did not receive any compensation.
Data Management and Analysis
Interviews were transcribed by OB and RH, with translation
of Setswana into English by OB. Transcripts were analyzed
using Dedoose web-based software (SocioCultural Research
Consultants, LLC, Los Angeles, USA). Demographic data were
collected on a REDCap (Research Electronic Data Capture)
database. Interview transcripts were analyzed using thematic
content analysis (16) by a team of three research members
(RH, AMG and OB). An initial codebook of codes and
sub-codes was developed based on emerging themes in the
user interviews. The codebook was revised through review of
field notes and discussion with the analysis team, and was
further revised following completion of the provider interviews.
Some codes were developed as being relevant to themes
expressed by both users and providers, and other codes were
developed as being specific to one participant group. Please see
Supplementary Tables 1, 2 for a summary of key codes. Initial
coding was done by RH, then codes and associated transcript
excerpts were reviewed by AMG and OB for relevance and
discussion. After coding, further analysis was completed using a
matrix framework to aid grouping of themes. Interpretation of
linkages and meaning was discussed by the analysis team, and a
consensus was reached on the key themes. All discussions took
place via telephonic consultations.
RESULTS
User Characteristics and History of
Accessing Implant Services
In order to reach data saturation, ten in-depth interviews were
conducted with women who had previously undergone removal
of the contraceptive implant. User interviews were in English (n
= 1), Setswana (n = 4), or a mixture of English and Setswana (n
= 5), with a mean duration of 38 min.
User characteristics are presented in Table 1. Median age
of users was 25.5 years (range 22–38 years). One user had
used Jadelle R© and nine had used Implanon NXT R©. Insertions
had been performed at six different healthcare facilities: three
government clinics in Gaborone (n = 5); one NGO clinic in
Gaborone (n = 3); one government clinic in an outlying district
(n = 1); and one government hospital in an outlying district
(n = 1). The median interval between implant insertion and
removal was 137 days (range 68–679 days). Primary reasons
for removal were side effects (n = 9, principally amenorrhoea,
irregular vaginal bleeding, headache and weight gain) and desire
to conceive (n= 1).
Seven of the ten users had made two or more clinic visits
while seeking implant removal, and for four users these visits
had been made to two or more different clinics. The approximate
interval from initial request to undergoing removal ranged from
the same day to 3 months. Removals had almost exclusively
been performed at the NGO clinic, with one exception: one user
who had used a Jadelle R© implant had undergone two removal
procedures; one rod had been removed at a government clinic in
Gaborone, and the second rod was removed at the NGO clinic
after referral.
Following implant removal, none of the users had
chosen to use the implant again by the time of interview.
Three users switched to the male condom, two switched
to the oral contraceptive pill, one switched to the DMPA
(depomedroxyprogesterone acetate) injection, and one was
relying on withdrawal. Three users did not restart any method
of contraception. This was due to desire to conceive (n = 1),
current sexual abstinence (n = 1), and wanting to “recover from
all the hormones” (n = 1). Two of the three users who switched
to condoms also stated that they wanted to avoid hormonal
methods of contraception.
Provider Characteristics and Professional
Experience
Ten in-depth interviews were conducted with providers who had
experience in providing implant services. All provider interviews
were in English, with a mean duration of 58 min.
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TABLE 1 | User characteristics and history of accessing implant services.
Characteristic n = 10





Highest level of education
Junior secondary 1 (10%)




















Age at first pregnancy (years) 21 (17–22)
Age at most recent pregnancy (years) 22 (19–29)
Type of implant used
Implanon NXT® 9 (90%)
Jadelle® 1 (10%)
Primary reason for removal
Side effects 9 (90%)
Desire to conceive 1 (10%)
Number of clinics attended for insertion
1 9 (90%)
>1 1 (10%)












<1 week 1 (10%)
(Continued)
TABLE 1 | Continued
Characteristic n = 10
1–2 weeks 4 (40%)
3 months 2 (20%)
Interval between insertion and removal (days) 137 (68–679)
Other methods of contraception ever used
Copper IUD 1 (10%)
DMPA injection 5 (50%)
Oral contraceptive pill 4 (40%)
Male condom 9 (90%)
Withdrawal 1 (10%)
All data are presented as n (%) or median (range); HIV, human immunodeficiency virus;
IUD, intrauterine device; DMPA, depomedroxyprogesterone acetate.
TABLE 2 | Provider characteristics and professional experience.
Characteristic n = 10
Total clinical experience (years) 16 (6–23)
Duration in current post (years) 3 (1.5–8)
Type of implant covered in training
Implanon NXT® 6 (60%)
Jadelle® 2 (20%)
Both 2 (20%)
Interval from original training to interview (months)* 23 (8–27)
Has undergone refresher training
Yes 6 (60%)
No 4 (40%)
Estimated number of insertions performed 125 (40–400)
Estimated number of removals performed 15 (0–100)
*Data were only available for 9 providers.
All data are presented as n (%) or median (range).
Provider characteristics are presented in Table 2. Nine
providers were female, and one was male. Providers were based
at eight different healthcare facilities in the Gaborone area:
one NGO clinic; six government clinics; and the gynecology
department of a main government hospital. All providers had
completed nursing training, eight had undergone additional
midwifery training, and two had undergone additional implant
training to become Master Trainers in the Botswana implant
program. Six providers had been trained on Implanon NXT R©,
two had been trained on Jadelle R©, and two (the Master Trainers)
had been trained on both types of implant. All providers had
undertaken their original implant training through the Botswana
implant program between July 2016 and October 2017, and
six had undertaken refresher training. The median number of
insertions per provider was 125 (range 40–400) and the median
number of removals was 15 (range 0–100). One provider had not
performed any removals due to no demand at her clinic.
Barriers Experienced in Accessing Implant
Removal Services
Three users reported no barriers to accessing implant removal
services and had undergone this procedure on the day of their
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first clinic presentation for removal. The other seven users had all
experienced delays. The principal reasons for delays were lack of
access to trained removal providers, inconvenient appointment
times, and provider resistance to remove the implant.
For many users, delay in accessing implant removal was due
to no trained removal provider being available at their local clinic
leading to repeat visits to multiple clinics. In some cases, users
made an appointment at the first visit and later returned to the
same clinic on a day when a removal provider was available. In
other cases, no removal provider was working at the first clinic
so users visited other clinics in search of a trained provider.
Users questioned the underlying programmatic setup which led
to such circumstances: “I failed to understand why a clinic that
does implant insertions could not have personnel that remove it. It
does not make sense to me” (User 02, age 35).
Even when a removal provider was available, users highlighted
inconvenient appointment times as an additional barrier to
accessing implant removal. This led to further delays, and several
users had missed school or work to attend the clinic.
Judgmental provider attitudes or perception of providers as
being resistant to users discontinuing the implant was a recurrent
theme in user interviews. Interactions of this nature became a
negative part of users’ implant experiences. One user explained
that, “I personally really liked the implant. It is just that when
it comes to removing it, healthcare providers become really slow
and reluctant in removing” (User 05, age 38). In some cases, users
perceived resistance from providers whowere not able to perform
removals: “I first went to [a government clinic], and when I got
there and told them I want to remove the implant, they said ‘What?
We do not do that here,’ with that attitude” (User 02, age 35). In
other cases, providers had undergone implant removal training
but attempted to persuade users to continue using the implant
until its expiry date. One user described how “[The provider] was
advising me against it ‘no, just finish off, you are not left with much
time”’ (User 08, age 28). These descriptions were corroborated
by providers who had heard of colleagues expressing negative
attitudes toward patients: “They [users] will say, ‘they [providers]
were not friendly’, so they will be going from one clinic to another,
to another” (Provider 07, government clinic).
The narratives of two users, whose experiences illustrate these
themes, are summarized in Table 3 as Narratives A and B.
Barriers Experienced in Providing Implant
Removal Services
Providers described the principal barriers to providing implant
removal services as insufficient training, lack of equipment, lack
of time, and lack of a referral pathway for difficult removals.
Only one provider stated that they had experienced no barriers
to providing removals.
In common with users, providers reported there was a lack of
trained removal providers. They described being the only trained
provider at their clinic and not always being available to perform
implant removals: “I’m alone here: I’m the one who’s doing the
insertions, I’m the one who’s doing the removals. And I’m working
on shifts. Sometimes they come here and I’m not here. I’m off or
I’m on night duty” (Provider 10, government clinic); “Patients
come here, they don’t find me, they get frustrated” (Provider 06,
government clinic).
In addition to a lack of fellow providers, they also felt that
implant training had been deficient in some aspects. Not all
providers felt competent to provide insertions and removals
following basic training, but they felt that subsequent MoHW
mentoring and refresher training had addressed these concerns.
Most providers described insufficient focus on removals in basic
implant training, including insufficient practical experience:
“The theory part was sufficient but the practical part was not
so sufficient” (Provider 01, NGO clinic). Another issue was
insufficient training on removal of the two-rod Jadelle R© vs.
training on removal of the one-rod Implanon NXT R©: “I still
struggle with removing some implants, especially the Jadelle R©,
because the rods. . . slip around and they run around when you
try. . . It is really easy to remove the Implanon NXT R© but the
Jadelle R© still gives me a headache.” (Provider 06, government
clinic); “When I came to practice, I could see that I am having
challenges with the removal of certain implants. . . it takes me less
than a minute to remove the Implanon [NXT] R©, but when it
comes to Jadelle R© it is a challenge because it is more flexible and
sometimes when it is inserted, maybe it is not in the V like it is
supposed to be” (Provider 07, government clinic).
Most providers said that they lacked some of the key
equipment for providing implant removals, particularly gloves
and mosquito forceps which are in short supply and are
also required for the provision of other services such as
infant circumcision.
Provision of other services also requires providers’ time,
leading them to feel like they have insufficient time to perform
implant removals in the face of competing demands and with “so
many clients queuing” (Provider 07, government clinic).
Difficult removals encompass more challenging removals of
implants which are not easily palpable in the usual location due to
incorrect insertion or subsequent migration. Safe removal of this
subset of implants requires additional expertise or equipment.
Providers felt that they had undergone insufficient training on
difficult removals: “Training was sufficient for correctly inserted
implants, and not necessarily for difficult removals” (Provider
01, NGO clinic). Most providers recalled being taught not to
attempt difficult removals: “I think if I have got a difficult
one, I will phone one of the doctors and I will refer. Because
it has been stated clearly: if you realize the implant is deep,
do not even try it, that’s the thing” (Provider 10, government
clinic). Most providers were able to identify one or two
destinations to which they would refer patients for difficult
implant removals. This included the NGO clinic (n = 6), a
main government hospital (n = 2), directly to the lead SRH
consultant (n = 2), or that they would seek advice from the
MoHW family planning team (n = 1). One provider at the
NGO clinic did not have a referral pathway beyond their
own clinic.
In addition to referring users to other providers for difficult
removals, providers also overcome some of the barriers to
standard removals by referring users to alternative providers.
Referrals enable women to access services, even if their local
provider is not available: “Instead of just tossing patients here
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TABLE 3 | Illustrative narratives of user experiences accessing implant removals services.
Narrative A:
User 01 is aged 25 years and has one child. She used an Implanon NXT® implant for 15 months but decided to remove it due to associated side effects. She had
experienced recurrent headaches, tiredness and weight gain since initiating the implant. She also disliked the loss of her usual menstrual cycle, “I was not getting my
period, I just felt dirty.” She felt that providers failed to address her concerns, “I just feel that I was not listened to, both the two nurses did not listen to me.” She
attended three different clinics seeking implant removal, “I have been going to clinics for months now looking to remove it.” She encountered provider resistance at the
first clinic, “I kept being postponed… [The provider] said that she doesn’t know what it is with women, they come running to insert the implant and then they are the
very same people who come running to have it removed.” At the second clinic, she could not get an appointment because there was only one implant provider, “When
I got there the lady would always yell and put down dates for me that were very inconvenient as I was still working at the time.” She underwent implant removal at the
third clinic, the NGO clinic, after a total delay of 3 months.
Narrative B:
User 05 is aged 38 years, has three children and lives in a village to the west of Gaborone. She used a Jadelle® implant for 5 months after having it inserted at a
government clinic in her neighboring village. She disliked side effects, including lack of menstrual bleeding, and also experienced abdominal pain. First, she went to the
clinic where she had the implant inserted, “where I was given the runaround and they just refused and I gave up.” This clinic encouraged her to persist with the implant
and advised that it might not be the cause of her symptoms. Then she went to a government clinic in a neighboring town, “where I went several times until I gave up.”
She then traveled 40 km to a government clinic in Gaborone, where she encountered further resistance from the providers and made multiple visits to request implant
removal. “After going there several times, and only upon realizing that I meant business about removing, the nurse actually removed one [rod] and then she tried
removing the second [rod] but realized that she could not because it was too deep.” The nurse referred her to the NGO clinic where the second rod was safely
removed. Overall she visited four clinics, two of which on multiple occasions, and had a delay of 3 months from initial request to obtaining implant removal.
Narrative C:
User 06 is aged 23 years and has one child. She usually goes to the NGO clinic for family planning services, and this is where she had an Implanon NXT® implant
inserted. She had the implant removed at the same clinic two and a half months later due to side effects (headache, irregular vaginal bleeding). She had no delay to
removal, having had it removed at her first clinic visit requesting removal (“It was very easy, they didn’t give me any grief”).
NGO, non-governmental organization.
and there, we tell them where to get the services” (Provider 09,
government clinic).
Providers’ narratives offered an explanation for their perceived
resistance to performing removals, which had emerged as a
recurrent theme in the user interviews. Providers described a
conflict between promoting the rights of individual women to
discontinue the implant, against their perceptions of the financial
impact of early removal on the national family planning program.
Some providers identified the cost of the implant as a factor which
would dissuade them from removing it before its expiration date:
“But this thing is expensive, you think, ‘Ah, no, how could you?’ She
inserted in March and she removed last week. Three months. The
Jadelle R©, five year one” (Provider 06, government clinic).
Impact of Removal Services Experiences
on User Perceptions of the Implant
User perceptions of the implant were influenced by the
whole experience from counseling and initiation, to implant
use, and eventual discontinuation. Our study focused on this
final step: accessing services and undergoing removal for
implant discontinuation.
Most users had encountered barriers to accessing removal
services, as described above. Three users, all of whom had
presented directly to the NGO clinic for implant removal, had
not encountered any barriers to accessing these services. An
example of one user who described a positive experience of
accessing implant removal services is summarized as Narrative
C in Table 3.
Before actually undergoing removal, many users were fearful
of the invasiveness of the removal procedure: “I was just afraid
of being cut open” (User 04, age 24). Half of users felt that
they had been counseled insufficiently, or not at all, about the
removal procedure at the time of implant insertion. Lack of
information stoked anxiety about undergoing removal: “I was
really scared because I didn’t know what was going to happen. I
wasn’t comfortable because I didn’t know how it is removed” (User
06, age 23). However, other users praised the counseling they
had received and consequently felt less anxious: “I understood,
they were really honest about it” (User 08, age 28). In contrast to
users’ mixed reports of information received during counseling,
all ten providers said that they included information about
removal as part of their usual pre-insertion counseling. However,
they tended to focus on possible reasons for removal (with an
emphasis on side effects) and where to access removal services,
rather than the nature of the procedure itself.
All users interviewed were pleased with the quality of the
removal procedure they had undergone and had confidence in
the skills of their removal providers. Users’ comments about
removal included: “It wasn’t even painful” (User 01, age 25); “They
were very nice. I was in good hands” (User 04, age 24); “It didn’t
take as long as I thought it would. I think they handled it well”
(User 07, age 26).
Users perceived that the positive aspects of their implant
experience (reliable and convenient long-acting contraception)
outweighed the negative aspects (side effects, difficulty in
obtaining removal): “It works and does what it is supposed to do
which is prevent pregnancy, so really, I respect it” (User 04, age
24), “When the good surpasses the bad then everything is good”
(User 08, age 28). Users’ assessment of the implant being overall
advantageous led the majority to say that they would consider
using it again in the future. Most users cited an improvement
in side effect profile as being the factor which would most
attract them to choosing the implant again. For many users,
their experience of side effects had been more negative than their
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experience of using removal services. All users said that they
would recommend the implant to other women. Users wanted
to improve access to services for initiating the implant so that
potential users could follow up on their recommendation: “I wish
[the implant] could be easily accessible and available everywhere.
With me, I managed to get it because I was persistent. . . You
[should not] have to move from clinic to clinic looking for [implant
insertion services]” (User 02, age 35).
Users reasoned that others might not experience the same side
effects and that they could benefit from the positive attributes
of the implant. For example: “It really is a good method and
it’s effective. Just that I was unlucky it didn’t agree with me,
but it’s a good method” (User 03, age 22); “People are different.
The implant might be good for someone but it can also be not
good for other people, but I would recommend that people use it”
(User 06, age 23). In addition to the previously well-documented
side effect of heavy or prolonged vaginal bleeding leading to
implant discontinuation, participants in our study also identified
lack of bleeding (i.e., oligo- or amenorrhoea) as a reason for
early implant discontinuation. Users believed menstruation to be
associated with bodily cleansing and therefore associated lack of
regular menstruation with uncleanliness: “I just did not like that I
wasn’t cleansing monthly” (User 09, age 27).
Overall, despite encountering barriers in accessing removal,
users’ perceptions of the implant remained positive. Perceptions
had been damaged to a greater degree by issues with side
effects than they had by the difficulties experienced in accessing
removal services.
Impact of Removal Services Experiences
on Providers’ Perceptions of the Implant
In contrast to the perceptions of users, providers expressed
greater concern that ongoing negative experiences of removal
services would lead to user dissatisfaction and endanger the
overall image of the implant: “I strongly believe it is going to
affect the insertion rate of implant. Because if they share that
they wanted to remove it but they couldn’t, I don’t think other
people are going to want to insert. It is frustrating” (Provider
06, government clinic). Other providers thought that women’s
current experiences might generate negativity toward individual
clinics or providers, rather than toward the method as a whole: “I
don’t think that gives them a bad perception towards the implant
as a method, rather it will be towards us as providers” (Provider
02, NGO clinic).
Providers agreed with users in calling for increased access
to implant insertion services. Providers overwhelmingly thought
that the implant was a suitable method of contraception for
Botswana and that it should be promoted widely, despite existing
barriers with removal services.
Recommendations for Improving Access
to Implant Removal Services
Participants from both groups suggested that access to removal
services could be improved by strengthening provider training.
In addition to training more providers, participants also called
for improved training of existing providers in relation to the
whole implant user journey: pre-insertion counseling, insertion,
counseling during use, and removal.
Providers perceived that poor insertion techniques,
particularly deep rod placement, led to subsequent difficult
removals. They lacked confidence in technical skills for
performing implant removals following initial implant training.
They spoke positively about subsequent in-service training
which, they reported, was effective in improving their skills and
competency. Providers also called for more practical sessions in
implant training, and ongoing in-service training and mentoring
to improve standards in both insertion and removal.
Users and providers consistently recommended that better
counseling should be provided to improve experiences with
implant services in the future. Half of users felt that they had
received insufficient pre-insertion counseling about the eventual
removal procedure, despite all ten providers saying that they
routinely counsel potential implant users about discontinuation
and removal. One provider thought that improved pre-insertion
counseling on possible side effects would lead to fewer users
choosing early implant removal: “You find that in most cases
there has been insufficient counseling prior to the insertion because
when you do the further counseling, the clients then decide to keep
the implant” (Provider 01, NGO clinic). The same theme was
expressed in one of the user interviews: “So because the nurse
explained [possible side effects] tome I wasn’t that worried. Because
they told us that others you would spot [experience irregular light
vaginal bleeding] every day, whereas with others the period would
diminish” (User 08, age 28).
Many users had encountered provider resistance to early
removal of implants before their expiration dates. One provider
emphasized the importance of upholding each woman’s right to
discontinue the implant when they choose to and thought that
fellow providers should have increased training on facilitating
users’ choice: “We should focus a lot on. . . talking to the service
providers about the clients’ rights to remove the implant when they
want to. . . Sometimes [providers] refuse to remove [the implant],
citing things like ‘it’s expensive’ and ‘you have just recently inserted
it.’ If the client is uncomfortable then they are free to remove [the
implant]. We should put more emphasis on that” (Provider 01,
NGO clinic).
Users and providers highlighted the need to address
inequalities in access to SRH services, including the implant, for
women living in rural areas: “[In the] remotest areas, they really
don’t know anything about [the implant], they really don’t. Yes.
And also, because the healthcare providers, they don’t know about
the methods, they don’t give information about it” (Provider 09,
government clinic); “Go out there and teach women. And take the
services to women in rural areas” (User 04, age 24).
DISCUSSION
This study addresses an important aspect of contraceptive
implant provision: implant removal. We sought to gain an
understanding of experiences with implant removal from the
perspective of both users and providers of implant services in
the resource-limited setting of Botswana. Existing studies have
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investigated overall perceptions of the implant, reasons for early
implant removal, and in a few cases, experiences of accessing
implant removal services (17, 18).
Our study offers insight into the existing barriers and
how these might be addressed to improve access to implant
removal services. Across both participant groups, the principal
barriers to accessing implant removal services were identified
as: lack of trained removal providers and therefore lack of
provider time; lack of equipment; lack of a referral pathway for
difficult removals; inconvenient appointment times and provider
resistance to performing early removals. These barriers are
interrelated and can be classified under two broad areas: human
resources and supply chain management.
In terms of human resources, lack of trained removal
providers leads to lack of time on the part of providers who
have been trained, which in turn leads to limited and sporadic
provider availability such that women seeking implant removal
have to make multiple clinic visits or attend at inconvenient
times. In our study, many providers who had undergone basic
implant training described a lack of confidence in performing
removals independently in their clinics, effectively subtracting
themselves from the number of removal providers which would
have been expected, based on the number trained. This finding is
consistent with providers’ experiences following implant training
in neighboring South Africa (19).
Even with improved provider training for standard implant
removals, additional training and/or improved referral pathways
will be required to address difficult implant removals for a
small subset of users. One study of Implanon NXT R© found that
13.7 per 1,000 removal procedures were classified as difficult
(20). There is a lack of quantitative data on difficult removal
rates for Jadelle R©, nor comparison of rates of difficult removals
between Implanon NXT R© and Jadelle R©. Specialist services for
difficult implant removals have been established in other settings,
including elsewhere in sub-Saharan Africa (21). Providers in our
study identified where they would refer users for difficult implant
removals, and for six providers, this destination was the NGO
clinic. All users in this study underwent removal at the NGO
clinic, but only one would likely have been classified as a difficult
removal. This suggests that the NGO clinic is frequently being
used for standard removals through provider referrals and user
self-presentations, which could reduce its capacity to provide
services for difficult removals.
Providers in this study perceived Jadelle R© as being technically
more challenging to remove than Implanon NXT R©. Removal
of Jadelle R© can be facilitated by using the modified vasectomy
clamp technique (22), but providers rarely have access to this
equipment in Botswana. Additionally, six of the ten providers in
this study did not receive specific training on Jadelle R©, which
may have affected their perceptions of the difficulty of the
removal process. In South Africa’s Western Cape Province, all
Jadelle R© implants are considered difficult to remove by default,
and women are referred to a specialist difficult removals clinic
(22). However, Jadelle R© is not provided in the South African
public health sector, whereas it is provided in the Botswana public
health sector so we might reasonably expect implant providers to
be able to remove as well as insert this implant model. Results
from this study indicate that more training on how to remove
Jadelle R© is needed so that providers in Botswana are confident in
providing removal services for both types of implants.
This study also suggested that there is insufficient supply
chain management, evidenced by a lack of equipment and
disposable commodities. In some cases, even if the human
resource challenges had been met and a trained, competent
provider was available at a time and location accessible and
convenient to users requesting the service, supply issues could
still thwart provision of implant removals.
Botswana has addressed human resource and supply chain
challenges to successfully upscale provision of implant insertion
services, but our findings suggest that further work is needed
in upscaling provision of removal services. In the early days
after implant introduction in Botswana, and in common with the
experience of SRH services elsewhere (4), demand for insertions
was higher than demand for removals and the focus was on
insertion services. However, over the course of her reproductive
life, each woman who uses the implant will likely undergo the
same number of removals as insertions. Therefore, upscaling of
implant removal services needs to be given sufficient attention
in order to match the pace set by implant insertion services.
All users in our study accessed implant removal at the NGO
clinic, and the majority of providers identified this clinic as the
healthcare facility to which they would refer patients for implant
removal. Use of the NGO clinic as the main removal center
might not be sustainable as a long-term strategy for provision
of removal services. In other countries, integration between
public sector health services andNGOs has strengthened capacity
for provision of implant services, including those for implant
removals. Examples of NGO and public sector collaboration
for implant service provision include a Population Services
International program for LARC initiation in Zambia (23)
(though the description of this program does not specify services
for LARC discontinuation i.e., implant removal), as well as the
work of Marie Stopes International in provision of implant
services in multiple countries across sub-Saharan Africa (24).
The principle of reproductive autonomy should be
fundamental to the provision of all contraceptive services
(25) and is key to the interpretation of our study findings.
Women’s reproductive rights are supported through full, free
and informed choice about contraceptive options, and relate
not only to facilitating the decision to start contraception, but
also the decision to stop contraception (11, 26). Full choice is
facilitated through the availability of accessible services for the
initiation of a wide range of contraceptive methods, but also
through the availability of accessible services for discontinuation
of these methods. Free choice depends on women being able
to voluntarily choose to use or not use contraception without
barriers or coercion. Informed choice requires that women
are provided with sufficient accurate information about the
contraceptive methods available to them, upon which they can
base their decision-making (11). Challenges to all three of these
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principles were evidenced in our study: lack of access to implant
removal services undermined women’s full choice; provider
resistance to performing early removals undermined women’s
free choice; poor pre-insertion counseling, including provision of
information about the eventual removal procedure, undermined
women’s informed choice.
Provider resistance to performing removals has been noted
in other settings where the implant is a novel method of
contraception (27). This has been reported with current implant
models, such as Implanon NXT R© in South Africa (28), Ghana
(18) and the United Kingdom (17), and with historic implant
models, such as Norplant R© in Indonesia (29) and Senegal (30). In
our study, providers cited cost as a factor which dissuaded them
from performing early removals because reducing the implant’s
lifespan decreases its cost-effectiveness. However, providers did
not appear to weigh this financial expense against that associated
with unintended pregnancies.
Our findings suggest that provider training needs to be
reviewed to address deficiencies in pre-insertion counseling and
improve support of women’s right to choose early removal. Some
users in our study chose to discontinue the implant due to
lack of menstrual bleeding, and previous research has found
a broad global variation in acceptability of bleeding changes
caused by hormonal contraception (31). This highlights the need
for context-specific, culturally-sensitive counseling throughout
SRH services, including those for implant provision, particularly
around expected side effects and how they can be managed.
Providers can only offer a full choice of contraceptive options
if the system they work in enables them to do so; therefore,
management of the supply chain is needed in addition to
individual provider training in order to facilitate women’s full,
free and informed contraceptive autonomy.
A key aim of our study was to elicit if personal experiences
of the existing implant services were likely to impact upon wider
perception of the implant as a method of contraception. Women
who had encountered barriers to accessing implant removals
were disappointed with this aspect of the service but remained
positive about the method as a whole and said that they would
recommend it to friends. Providers struck a more cautious note,
expressing concerns that ongoing challenges in accessing implant
removals would eventually damage the reputation of the implant
and potentially reduce its uptake. This has already been witnessed
in South Africa (28), where some users have resorted to removing
their own implants (32). Women in our study had chosen to
initiate the implant after hearing positive reviews from peers,
so negative reviews might dissuade women from choosing the
implant in the future. If access to implant removal services is not
improved, a negative perception could develop amongst current
users, potential users, and providers, which could lead to a decline
in implant uptake.
Users’ and providers’ perceptions of contraceptive implants
could also influence their future views about other types of
implants, such as those currently in development for HIV
prevention (33–35) and multipurpose prevention of both HIV
and pregnancy (36). Given the high HIV prevalence in Botswana
(25.1% among women of reproductive age) (37) and potential
for these new implantable technologies to greatly reduce HIV
incidence, it is crucial that current contraceptive implant services
are optimized to pave the way for new types of medical implant.
LIMITATIONS
This study has several limitations. It is small in size, and all
users were recruited from and had undergone removal at one
clinic. However, some users had tried to access removal services
at six different clinics before eventually undergoing removal
at the same clinic. The experiences of these users might not
be representative of users who do successfully access implant
removal services at other clinics. In the case of five users who
presented directly to the NGO clinic for removal but who had
originally inserted the implant elsewhere, we did not explore
why they chose this clinic rather than attempt to obtain implant
removal at the clinic of insertion. Both users and providers
had experienced accessing and providing services in an urban
setting, so their experiences might not be representative of
implant services in rural areas. The users interviewed in this
study were recruited opportunistically and had all sought early
discontinuation of the implant; therefore, they may not be
representative of the whole population of implant users, many
of whom do not discontinue early. In common with other
qualitative studies, there is also a risk of social desirability bias
influencing participants’ responses. Nevertheless, it is important
to evaluate users’ perspectives following the introduction of
any new contraceptive method (38). Since the implant was
introduced in Botswana in 2016, participants in our study
represent users and providers who have been the first to
experience Botswana’s implant removal services.
CONCLUSION
Upscaling provision of the contraceptive implant is an important
strategy in increasing access to LARCs and promoting the
reproductive health rights of women throughout low-resource
settings. Expansion of implant services initially focused on
insertions, while services for removals have lagged behind. Our
study found that implant users and providers have experienced
challenges in accessing and providing removals. For users,
these challenges are principally in relation to an insufficient
number of trained removal providers and provider resistance to
performing early removals. For providers, the main challenges
are an insufficient number of colleagues who are trained removal
providers, insufficientmaterials, and lack of a referral pathway for
difficult removals. It will be important to address these areas so
that universal contraceptive access is achieved, including access
to the means of method discontinuation. Access to removal
services is a vital component in upholding women’s contraceptive
autonomy and maintaining user satisfaction with the implant.
The findings of this study could help inform the ongoing
development of services for implant insertion and removal
in Botswana. We hope that other national SRH programs,
particularly those operating in resource-limited settings, will
benefit from learning about our experience.
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